Health ❯ Pharmaceuticals

Weight Management

Obesity Treatment GLP-1 Agonists GLP-1 Drugs Injectable Drugs Obesity Drug Safety Access to Medication Wegovy Medications GLP-1 Receptor Agonists Ozempic Drug Approval GLP-1 Treatments Zepbound Diabetes Treatment Weight Loss

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Investors focus on Lilly’s reliance on two injections for more than half of 2025 sales.

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.